Life Sciences DNA Podcast
Episodes
Finding ROI from AI in the Mundane
09 Apr 2026
Contributed by Lukas
Dennis Salotti, executive director and head of clinical outsourcing and innovation at Jazz Pharmaceuticals, joins Srivatsan Nagaraja to talk about wha...
A Pragmatic Path to AI-Enabled Commercial Operations
26 Mar 2026
Contributed by Lukas
Tris Pharma Chief Commercial Officer Manesh Naidu sits down with Nagaraja Srivatsan to discuss how the small but growing specialty pharma company is...
Reimagining Scientific Work in the Age of AI Agents
12 Mar 2026
Contributed by Lukas
Shweta Maniar, global strategy and market leader for life sciences at Google Cloud, sits down with Nagaraja Srivatsan to unpack what it takes to turn ...
Orchestrating Scientists, Data, and AI to Discover New Drugs
26 Feb 2026
Contributed by Lukas
Scotch McClure had a bold plan for Maxwell Biosciences to map and mine the roughly 3 percent of peptides circulating in human plasma. The company has ...
Scaling Practical AI Across Commercial Teams
12 Feb 2026
Contributed by Lukas
Drew McCormick, head of data and analytics at Eversana, sits down with Nagaraja Srivatsan to trace the company’s AI journey from classic predictive ...
Building an AI-Ready Biopharma Organization
08 Jan 2026
Contributed by Lukas
Scott Cenci, chief information and data officer for Acadia Pharmaceuticals, sits down with Nagaraja Srivatsan to discuss how generative and agentic AI...
Automating Biopharma Workflows with AI and Robotics
24 Dec 2025
Contributed by Lukas
Karthik Raman, co-founder and CEO of Persist AI, sits down with the Nagaraja Srivatsan to discuss how robotics, AI, and cloud tech are supercharging d...
De-Risking Discovery and Improving the Success Rates of Drug Development with AI
11 Dec 2025
Contributed by Lukas
Gabi Tarcic, vice president of product for Evogene, sits down with Srivatsan Nagaraja about applying AI to small molecule drug discovery, the cultural...
Agents of Change: Creating Regulatory Documents with AI
26 Nov 2025
Contributed by Lukas
Anita Modi, CEO and founder of Peer AI, joins Srivatsan Nagaraja to discuss the transformative impact of agentic AI on document creation for pharmaceu...
Redefining Biomarkers for Immune-Mediated Disease with AI
13 Nov 2025
Contributed by Lukas
Ronel Veksler, co-founder and CEO of PromiseBio, sits down with Amar Drawid to discuss the company’s AI-enabled proteomics platform, and how post-tr...
Driving Insights from Real World Oncology Data with AI
23 Oct 2025
Contributed by Lukas
Aaron Cohen, Head of Research Oncology, Clinical Data for Flatiron Health, sits down with Amar Drawid to discuss Flatiron’s use of large language mo...
Improving Drug Development with Real-World Data
09 Oct 2025
Contributed by Lukas
Manfred Stapff, founder and principal of Candid Advisory, sits down with Amar Drawid to discuss the potential of real-world data to accelerate drug de...
Navigating the AI Landscape in Clinical Development
25 Sep 2025
Contributed by Lukas
Stephen Pyke, chief clinical data and digital officer at Parexel, sits down with Srivatsan Nagaraja to discuss the adoption of AI technologies in clin...
Transforming Cancer Diagnostics and Care with AI
11 Sep 2025
Contributed by Lukas
Mohan Uttarwar, CEO 1Cell.Ai, sits down with Amar Drawid to discuss how his company is transforming cancer diagnostics and care by combining cutting-e...
Moving Beyond the Hype of AI in Biopharma
28 Aug 2025
Contributed by Lukas
Amar Drawid, vice president and global head of data analytics, insights, and AI for BioNTech, sits down with Nagaraja Srivatsan to discuss the evoluti...
Why AI’s Most Promising Near-Term Value Is in Clinical Operations
14 Aug 2025
Contributed by Lukas
Dimitris Agrafiotis, director of digital analytics and AI at Arsenal Capital Partners sits down with Nagaraja Srivatsan to discuss the current state o...
Teaching the Biopharma Workforce to Coexist with AI
24 Jul 2025
Contributed by Lukas
Sunil Talathi, senior director and head of data insights, data sciences, and analytics for BeOne Medicines; sits down with Nagaraja Srivatsan to discu...
Making Clinical Trials More Predictable with AI
14 Jul 2025
Contributed by Lukas
Craig Lipset, advisor and founder of Clinical Innovation Partners, sits down with Nagaraja Srivatsan to discuss how AI can bring greater predictabili...
Finding Healthcare Providers from Clinical Trials to War Zones
26 Jun 2025
Contributed by Lukas
Ariel Katz, co-founder and CEO of H1, sits down with Amar Drawid to discuss how his company’s AI platform allows pharmaceutical companies to identif...
Driving Efficiency in Drug Development with AI
12 Jun 2025
Contributed by Lukas
Venky Iyer, director of data strategy and automation at Pfizer, sits down with Nagaraja Srivatsan to discuss the transformative role of AI and machine...
Improving Clinical Trial Designs with AI
29 May 2025
Contributed by Lukas
Scott Chetham, co-founder and CEO of Faro Health, sits down with Amar Drawid to discuss how AI transforms clinical trial design and drug development. ...
Improving the Efficiency of the Pharma Workforce with AI
15 May 2025
Contributed by Lukas
Kannan Natarajan, senior vice president at Pfizer, discusses the potential of generative AI to streamline pharmaceutical documentation processes and i...
Navigating AI Implementation in Pharma
24 Apr 2025
Contributed by Lukas
Vinod Das, Pharma R&D, Drug Innovation & AI Scouting for Bayer; sits down with Nagaraja Srivatsan to discuss the integration of generative AI ...
Transforming Cancer Care in India with AI
10 Apr 2025
Contributed by Lukas
Vijayalakshmi Ramshankar, professor and head of the Department of Cancer Biology and Molecular Diagnostics at Cancer Institute (WIA) sits down with Na...
Navigating the Challenges of Integrating AI in Clinical Development
27 Mar 2025
Contributed by Lukas
Manoranjan Das, director of global drug development IT for Bristol Myers Squibb, sits down with Nagaraja Srivatsan to discuss his work to implement AI...
Leveraging AI in Clinical Development
13 Mar 2025
Contributed by Lukas
Aman Thukral, director of Clinical Systems And Digital Operations at AbbVie, sits down with Nagaraja Srivatsan to discuss the evolving landscape of cl...
Integrating AI into Precision Medicine
27 Feb 2025
Contributed by Lukas
Tobias Guennel, senior vice president of product innovation and co-founder of QuartzBio, joins Nagaraja Srivatsan to discuss his insights on leveragin...
Transforming Clinical Development with AI
13 Feb 2025
Contributed by Lukas
Bhaskar Sambasivan, CEO of Saama, sits down with Nagaraja Srivatsan to discuss the transformative role of AI in clinical development, why AI adoption ...
Generating Proteins Nature Never Imagined
12 Dec 2024
Contributed by Lukas
Mike Nally, CEO of Generate Biomedicines, sits down with Amar Drawid to discuss the innovative use of generative AI in drug discovery, how the company...
Why Data Strategy Must Be Tied to Business Outcomes
27 Nov 2024
Contributed by Lukas
Kannan Raman of Amazon Web Service sits down with Amar Drawid to discuss the role of AI in transforming life sciences and the importance of data strat...
Biopharma Companies Wrestle with an Outsized Demand for AI Talent
14 Nov 2024
Contributed by Lukas
The increasing demand for AI talent in the life sciences industry is presenting a challenge for biopharma HR departments. Companies must compete for s...
Using AI and Synthetic Biology to Go Where Antibody Therapies Can’t
24 Oct 2024
Contributed by Lukas
Monoclonal antibodies have been an important addition to the biomedical arsenal, but these therapies have limited ability to target a group of cell su...
Unlocking Market Access with AI
10 Oct 2024
Contributed by Lukas
Rick Lloyd, founder and senior healthcare advisor of Range Health Advisors, sits down with Amar Drawid to discuss the intricacies of market access in ...
Ensuring Successful Implementation of AI
03 Oct 2024
Contributed by Lukas
Anastasia Christianson, AI and data analytics senior consultant and strategic advisor to life sciences and healthcare companies, sits down with Amar D...
Tackling the New Bottleneck of Drug Discovery
12 Sep 2024
Contributed by Lukas
Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enable...
Swimming in the Deep End of AI
22 Aug 2024
Contributed by Lukas
Brendan Frey, founder and chief innovation officer of Deep Genomics, sits down with Amar Drawid to discuss how the company is using deep learning to l...
Using AI to Make Biology Easier to Engineer
25 Jul 2024
Contributed by Lukas
Ankit Gupta, the head of AI and Senior Director of Machine Learning Research for Ginkgo Bioworks sits down with Amar Drawid to discuss bioengineering ...
How AI ls Reshaping the Future of Healthcare
27 Jun 2024
Contributed by Lukas
Subodha Kumar, professor of statistics, operations, and data science and the founding director of the Center for Business Analytics and Disruptive Tec...
A Venture Studio with Big Pharma Backing Seeks to Fix Drug Development with AI
13 Jun 2024
Contributed by Lukas
Mati Gill, CEO of AION Labs, sits down with Amar Drawid to discuss how the AI venture studio works with its Big Pharma partners to define the biggest ...
Decoding the Immune System to Optimize Immunotherapies
30 May 2024
Contributed by Lukas
Noam Solomon, co-founder and CEO of Immunai, sits down with Amar Drawid to discuss how the company is using machine learning to take a multi-omics app...
Bringing Precision Medicine to Mental Health with AI
09 May 2024
Contributed by Lukas
Behavioral health is one area of medicine that has lagged in the move towards precision medicine, in part because of a lack of high-quality evidence t...
The Power and Peril of Generative AI in Biopharma and Healthcare
25 Apr 2024
Contributed by Lukas
Healthtech and AI Executive Advisor Christian Hein sits down with Amar Drawid to discuss the use of generative AI in the life sciences, its transforma...
Unlocking the Complexity of Disease with Transomics and AI
11 Apr 2024
Contributed by Lukas
Samantha Dale Strasser, co-founder and chief scientific officer of Pepper Bio, sits down with Amar Drawid to discuss how her company is leveraging AI ...
Why Biopharma Companies Should Recognize Data Analytics and AI as Strategic Advantages
28 Mar 2024
Contributed by Lukas
Nagaraja Srivatsan, founder of the consulting firm Vidya Seva, sits down with Amar Drawid to discuss the application of data analytics and AI to healt...
Making Undruggable Targets a Thing of the Past
14 Mar 2024
Contributed by Lukas
Jen Nwankwo, CEO of 1910 Genetics, sits down with Amar Drawid to discuss her company’s approach to AI drug discovery, how it is seeking to address b...
Using AI to Revolutionize Precision Oncology
22 Feb 2024
Contributed by Lukas
In this episode Tuvik Beker, CEO of Pangea Biomed, sits down with Dr. Amar Drawid to discuss the evolution of precision medicine, the challenges in ma...
Leveraging Data Analytics to Enhance Biopharma Sales
31 Jan 2024
Contributed by Lukas
Data analytics has evolved significantly in the pharmaceutical industry, providing sales professionals with better insights and decision-making capabi...